Ipragliflozin is an antihyperglycemic medication used to treat type 2 diabetes. It is a member of the sodium-glucose cotransporter 2 (SGLT2) inhibitor class of drugs. Ipragliflozin works by blocking the reabsorption of glucose in the kidneys, which allows the body to eliminate excess glucose in the urine. It also helps to reduce levels of HbA1C (a measure of average blood sugar levels over time) and can also be used to treat high blood pressure. Common side effects of Ipragliflozin include urinary tract infection, yeast infection, increased urination, nausea, and headache.
Ipragliflozin is a prescription medication used to treat type 2 diabetes. It belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. Here's a breakdown of its key features:
- Type of drug: SGLT2 inhibitor
- Function: Lowers blood sugar levels in people with type 2 diabetes [1].
- How it works: SGLT2 inhibitors work by blocking the SGLT2 protein in the kidneys. This protein is responsible for reabsorbing sugar (glucose) from the urine back into the bloodstream [1, 2]. By blocking this reabsorption, Ipragliflozin allows excess sugar to be eliminated through the urine, helping to lower blood sugar levels.
Here's a deeper look at some aspects of Ipragliflozin:
- Dosage: Ipragliflozin comes in tablet form and is typically taken once daily with or without food [1].
- Benefits: In addition to lowering blood sugar, Ipragliflozin may also offer other benefits for people with type 2 diabetes, such as weight loss and reducing blood pressure [2, 3].
Important considerations:
- Ipragliflozin is a prescription medication and should only be used under a doctor's supervision [1].
- It's important to discuss potential risks and side effects with your doctor before starting Ipragliflozin [1]. Some potential side effects include yeast infections, urinary tract infections, and dehydration [1].
- Ipragliflozin may not be suitable for everyone, particularly those with certain medical conditions or kidney problems [1].